{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:35:44Z","timestamp":1792575344135,"version":"4.5.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000782","name":"European Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01262","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T05:10:25Z","timestamp":1541999425000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":195,"title":["Updates in Anthracycline-Mediated Cardiotoxicity"],"prefix":"10.3389","volume":"9","author":[{"given":"Canan G.","family":"Nebigil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"D\u00e9saubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","article-title":"Cardiovascular disease after cancer therapy.","volume":"12","author":"Aleman","year":"2014","journal-title":"EJC Suppl."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/795602","article-title":"Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress.","volume":"2015","author":"Angsutararux","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ppedcard.2014.09.003","article-title":"Late cardiotoxicity in aging adult survivors of childhood cancer.","volume":"36","author":"Armstrong","year":"2014","journal-title":"Prog. Pediatr. Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1089\/scd.2014.0484","article-title":"The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review.","volume":"24","author":"Atashi","year":"2015","journal-title":"Stem. Cells Dev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11014","DOI":"10.1073\/pnas.0704002104","article-title":"Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.","volume":"104","author":"Azarova","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00922","article-title":"Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment.","volume":"9","author":"Battogtokh","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10522-013-9477-9","article-title":"A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta.","volume":"15","author":"Bielak-Zmijewska","year":"2014","journal-title":"Biogerontology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0590-0","article-title":"New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations.","author":"Bigagli","year":"2018","journal-title":"Invest New Drugs"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175544","article-title":"Anthracyclines induce early changes in left ventricular systolic and diastolic function: a single centre study.","volume":"12","author":"Boyd","year":"2017","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.exphem.2011.08.009","article-title":"The aging effect of chemotherapy on cultured human mesenchymal stem cells.","volume":"39","author":"Buttiglieri","year":"2011","journal-title":"Exp. Hematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1093\/nar\/gkn774","article-title":"Interaction of anthracyclines with iron responsive element mRNAs.","volume":"36","author":"Canzoneri","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators.","volume":"98","author":"Caplan","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1521020","article-title":"Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity.","volume":"2017","author":"Cappetta","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2015.12.008","article-title":"SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.","volume":"205","author":"Cappetta","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.freeradbiomed.2008.08.008","article-title":"Doxorubicin increases the susceptibility of brain mitochondria to Ca(2 + )-induced permeability transition and oxidative damage.","volume":"45","author":"Cardoso","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tox.2010.01.019","article-title":"Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy.","volume":"270","author":"Carvalho","year":"2010","journal-title":"Toxicology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1021\/cb400095v","article-title":"Targeted delivery of doxorubicin to mitochondria.","volume":"8","author":"Chamberlain","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1016\/j.bmcl.2013.07.070","article-title":"Doxorubicin-antioxidant co-drugs.","volume":"23","author":"Chegaev","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1021\/acs.jmedchem.6b00184","article-title":"H2S-donating doxorubicins may overcome cardiotoxicity and multidrug resistance.","volume":"59","author":"Chegaev","year":"2016","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1179\/joc.2010.22.6.402","article-title":"Overexpression of vascular endothelial growth factor 165 (VEGF(165)) protects cardiomyocytes against doxorubicin-induced apoptosis.","volume":"22","author":"Chen","year":"2010","journal-title":"J. Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clinbiochem.2014.10.013","article-title":"Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.","volume":"48","author":"Christenson","year":"2015","journal-title":"Clin. Biochem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management.","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tiv.2018.06.013","article-title":"Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.","volume":"52","author":"Damiani","year":"2018","journal-title":"Toxicol. In Vitro"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.109.895771","article-title":"Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.","volume":"121","author":"De Angelis","year":"2010","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2015.03.438","article-title":"SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.","volume":"189","author":"De Angelis","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mad.2016.05.004","article-title":"Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells.","volume":"159","author":"De Falco","year":"2016","journal-title":"Mech. Ageing Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","article-title":"Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.","volume":"111","author":"Dhingra","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"H1048","DOI":"10.1152\/ajpheart.01102.2007","article-title":"Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.","volume":"294","author":"Esaki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrcardio.2015.65","article-title":"Cardiotoxicity of anticancer treatments.","volume":"12","author":"Ewer","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124643","article-title":"Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes.","volume":"10","author":"Fabbi","year":"2015","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-06-3721","article-title":"Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury.","volume":"67","author":"Gabrielson","year":"2007","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077713","article-title":"Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division\/mitophagy inhibitor.","volume":"8","author":"Gharanei","year":"2013","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity.","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jpi.12176","article-title":"Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin.","volume":"57","author":"Govender","year":"2014","journal-title":"J. Pineal Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.breast.2017.10.010","article-title":"Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy + \/ - trastuzumab.","volume":"37","author":"Gujral","year":"2018","journal-title":"Breast"},{"key":"B41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2013.1554","article-title":"Activation of the p38 MAPK\/NF-kappaB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.","volume":"8","author":"Guo","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1159\/000356602","article-title":"Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK\/NFkappaB pathway in H9c2 cardiac cells.","volume":"32","author":"Guo","year":"2013","journal-title":"Cell Physiol. Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/CIRCRESAHA.117.311335","article-title":"Quaking inhibits doxorubicin-mediated cardiotoxicity through regulation of cardiac circular RNA expression.","volume":"122","author":"Gupta","year":"2018","journal-title":"Circ. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00018-015-2087-8","article-title":"Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy.","volume":"73","author":"Hamacher-Brady","year":"2016","journal-title":"Cell Mol. Life Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/eurheartj\/ehl044","article-title":"Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy.","volume":"27","author":"Hamed","year":"2006","journal-title":"Eur. Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"key":"B47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCULATIONAHA.109.902221","article-title":"Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice.","volume":"121","author":"Huang","year":"2010","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1210\/me.2009-0402","article-title":"Androgen receptor counteracts doxorubicin-induced cardiotoxicity in male mice.","volume":"24","author":"Ikeda","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/CIRCULATIONAHA.113.002203","article-title":"An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential.","volume":"128","author":"Jay","year":"2013","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1021\/acschembio.5b00268","article-title":"Mitochondrial targeting of doxorubicin eliminates nuclear effects associated with cardiotoxicity.","volume":"10","author":"Jean","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"47266","DOI":"10.1074\/jbc.M106829200","article-title":"Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase, effect of antiapoptotic antioxidants and calcium.","volume":"276","author":"Kalivendi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/10623320490904124","article-title":"Differential toxicity of anthracyclines on cultured endothelial cells.","volume":"11","author":"Kaushal","year":"2004","journal-title":"Endothelium"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33480","article-title":"Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes.","volume":"7","author":"Knowles","year":"2018","journal-title":"Elife"},{"key":"B55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/srep29994","article-title":"The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.","volume":"6","author":"Lazzarini","year":"2016","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1152\/physrev.00010.2014","article-title":"Paradoxical roles of antioxidant enzymes: basic mechanisms and health implications.","volume":"96","author":"Lei","year":"2016","journal-title":"Physiol. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","article-title":"Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease \u2013 Implications for therapy of heart failure.","volume":"116","author":"Lemmens","year":"2007","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1161\/CIRCULATIONAHA.105.560250","article-title":"Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.","volume":"113","author":"Li","year":"2006","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.105.568402","article-title":"Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.","volume":"113","author":"Li","year":"2006","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/748524","article-title":"Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.","volume":"2014","author":"Li","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1039\/C7NR08816G","article-title":"Mitochondria-based aircraft carrier enhances in vivo imaging of carbon quantum dots and delivery of anticancer drug.","volume":"10","author":"Li","year":"2018","journal-title":"Nanoscale"},{"key":"B63","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1074\/jbc.M308033200","article-title":"Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes.","volume":"279","author":"Lim","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","article-title":"Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.","volume":"30","author":"Lipshultz","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"H254","DOI":"10.1152\/ajpheart.01023.2001","article-title":"Melatonin as an effective protector against doxorubicin-induced cardiotoxicity.","volume":"283","author":"Liu","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"H660","DOI":"10.1152\/ajpheart.00268.2005","article-title":"Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure.","volume":"289","author":"Liu","year":"2005","journal-title":"Am. J. Physiol.-Heart C"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7207983","article-title":"Phytotherapy and nutritional supplements on breast cancer.","volume":"2017","author":"Lopes","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.01.002","article-title":"Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.","volume":"519","author":"Luo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","article-title":"Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.","volume":"67","author":"Lyu","year":"2007","journal-title":"Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.2459\/JCM.0000000000000383","article-title":"A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology.","author":"Maurea","year":"2016","journal-title":"J Cardiovasc. Med. (Hagerstown)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity.","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcha.2015.11.004","article-title":"Doxorubicin induced heart failure: phenotype and molecular mechanisms.","volume":"10","author":"Mitry","year":"2016","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168409","article-title":"An alpha-1a adrenergic receptor agonist prevents acute doxorubicin cardiomyopathy in male mice.","volume":"12","author":"Montgomery","year":"2017","journal-title":"PLoS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"H183","DOI":"10.1152\/ajpheart.00708.2014","article-title":"Mending a broken heart: the role of mitophagy in cardioprotection.","volume":"308","author":"Moyzis","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jacc.2007.03.057","article-title":"Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.","volume":"50","author":"Mukhopadhyay","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"H1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/S0024-3205(01)01352-2","article-title":"Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study.","volume":"69","author":"Murata","year":"2001","journal-title":"Life Sci."},{"key":"B78","first-page":"2175","article-title":"Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer.","volume":"22","author":"Nicolazzi","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.taap.2013.10.023","article-title":"Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts.","volume":"274","author":"Nordgren","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.toxlet.2013.11.023","article-title":"Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells.","volume":"224","author":"Oliveira","year":"2014","journal-title":"Toxicol. Lett."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-013-0334-4","article-title":"Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.","volume":"108","author":"Piegari","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tox.2016.09.011","article-title":"Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity.","volume":"370","author":"Pizarro","year":"2016","journal-title":"Toxicology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/cgt.2017.4","article-title":"Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity.","volume":"24","author":"Pop-Moldovan","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11906-009-0068-8","article-title":"Activation of the ubiquitin-proteasome system in doxorubicin cardiomyopathy.","volume":"11","author":"Ranek","year":"2009","journal-title":"Curr. Hypertens. Rep."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00280-011-1587-y","article-title":"The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats.","volume":"68","author":"Rao","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.","volume":"113","author":"Rasanen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","article-title":"An overview of doxorubicin formulations in cancer therapy.","volume":"10","author":"Rivankar","year":"2014","journal-title":"J. Cancer Res. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10741-017-9653-0","article-title":"Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.","volume":"23","author":"Ruggeri","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes.","volume":"51","author":"Sag","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","article-title":"Molecular mechanisms of mitochondrial autophagy\/mitophagy in the heart.","volume":"116","author":"Saito","year":"2015","journal-title":"Circ. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.4161\/cbt.11.12.15540","article-title":"Doxorubicin and daunorubicin induce processing and release of interleukin-1 beta through activation of the NLRP3 inflammasome.","volume":"11","author":"Sauter","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"B93","article-title":"Cardioprotection and second malignant neoplasms associated with dexrazoxane in children receiving anthracycline chemotherapy: a systematic review and meta-analysis.","volume":"108","author":"Shaikh","year":"2016","journal-title":"JNCI J. Natl. Cancer I"},{"key":"B94","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","article-title":"Mechanisms and management of doxorubicin cardiotoxicity.","volume":"36","author":"Shi","year":"2011","journal-title":"Herz"},{"key":"B95","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bcp.2012.10.005","article-title":"Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity.","volume":"85","author":"Sishi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","article-title":"Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications.","volume":"38","author":"Soultati","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015583","article-title":"p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.","volume":"5","author":"Spallarossa","year":"2010","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1172\/JCI32967","article-title":"The CO\/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.","volume":"117","author":"Suliman","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B100","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1021\/acs.molpharmaceut.8b00367","article-title":"Cargo-free nanomedicine with pH sensitivity for codelivery of DOX conjugated prodrug with SN38 to synergistically eradicate breast cancer stem cells.","volume":"15","author":"Sun","year":"2018","journal-title":"Mol. Pharm."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","article-title":"Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.","volume":"49","author":"Takemura","year":"2007","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.063","article-title":"Clarifying the proper definitions for type 2 myocardial infarction.","volume":"71","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058421","article-title":"Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse.","volume":"8","author":"Toldo","year":"2013","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.healun.2003.06.001","article-title":"Bone marrow is a source of regenerated cardiomyocytes in doxorubicin-induced cardiomyopathy and granulocyte colony-stimulating factor enhances migration of bone marrow cells and attenuates cardiotoxicity of doxorubicin under electron microscopy.","volume":"23","author":"Tomita","year":"2004","journal-title":"J. Heart Lung Transplant."},{"key":"B107","first-page":"266","article-title":"Managing cardiac risk factors in oncology clinical trials.","volume":"38","author":"Tsimberidou","year":"2011","journal-title":"Tex. Heart Inst. J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2174\/1389450116666150126105002","article-title":"Cardioprotection by targeting the pool of resident and extracardiac progenitors.","volume":"16","author":"Urbanek","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"B109","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","article-title":"Endothelial progenitor cells: characterization and role in vascular biology.","volume":"95","author":"Urbich","year":"2004","journal-title":"Circ. Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"11293","DOI":"10.1021\/bi971475e","article-title":"Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin.","volume":"36","author":"Vasquez-Vivar","year":"1997","journal-title":"Biochemistry"},{"key":"B111","doi-asserted-by":"publisher","first-page":"H1832","DOI":"10.1152\/ajpheart.01047.2009","article-title":"Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice.","volume":"298","author":"Vedam","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity.","volume":"95","author":"Vejpongsa","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"B114","first-page":"835","article-title":"[Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].","volume":"39","author":"Wang","year":"2017","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.3892\/ol.2016.4424","article-title":"Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.","volume":"11","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"B116","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1124\/jpet.111.189589","article-title":"Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy.","volume":"341","author":"Xu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B117","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/mol.105.013383","article-title":"Molecular pharmacology of the interaction of anthracyclines with iron.","volume":"68","author":"Xu","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/jat.3611","article-title":"Moving beyond the comprehensive in vitro proarrhythmia assay: use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.","volume":"38","author":"Yang","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/1534735415610427","article-title":"Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review.","volume":"15","author":"Yasueda","year":"2016","journal-title":"Integr. Cancer Ther."},{"key":"B120","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100876","article-title":"miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.","volume":"8","author":"Yin","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"B121","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"B122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/cvr\/cvw032","article-title":"Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity.","volume":"110","author":"Zhan","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"25152","DOI":"10.1021\/acsami.7b07219","article-title":"Trackable mitochondria-targeting nanomicellar loaded with doxorubicin for overcoming drug resistance.","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity.","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/srep44735","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T13:30:18Z","timestamp":1572615018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":125,"alternative-id":["10.3389\/fphar.2018.01262"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01262","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"article-number":"1262"}}